We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.4%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$149B
AUM Growth
+$5.43B
(+3.8%)
Cap. Flow
-$4.27B
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
30.32%
Holding
338
New
11
Increased
51
Reduced
229
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$151M |
| 2 |
Alibaba
BABA
|
+$115M |
| 3 |
XPeng
XPEV
|
+$79M |
| 4 |
Raymond James Financial
RJF
|
+$71.4M |
| 5 |
Allogene Therapeutics
ALLO
|
+$64.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$285M |
| 2 |
NetApp
NTAP
|
+$236M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$220M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$209M |
| 5 |
Adobe
ADBE
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.47% |
| 2 | Healthcare | 26.97% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Financials | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cisco
CSCO
$479B
| $475M | 0.32% |
8,957,190
-303,575
| -3% | -$16M |
|
77
Bath & Body Works
BBWI
$4.1B
| $459M | 0.31% |
7,876,058
-3,282,392
| -29% | -$177M |
|
78
Northern Trust
NTRS
$33.9B
| $455M | 0.31% |
3,935,137
-32,760
| -0.8% | -$3.76M |
|
79
Royal Caribbean
RCL
$85.6B
| $453M | 0.3% |
5,316,381
-119,650
| -2% | -$10.4M |
|
80
Meta Platforms (Facebook)
META
$1.51T
| $452M | 0.3% |
1,300,685
-64,450
| -5% | -$20.7M |
|
81
Corning
GLW
$143B
| $450M | 0.3% |
11,013,987
-745,238
| -6% | -$32.5M |
|
82
Entegris
ENTG
$23.2B
| $433M | 0.29% |
3,517,941
-145,000
| -4% | -$16.7M |
|
83
Textron
TXT
$15.4B
| $426M | 0.29% |
6,187,630
-111,130
| -2% | -$7.18M |
|
84
Agilent Technologies
A
$41.2B
| $423M | 0.28% |
2,862,741
-108,970
| -4% | -$14.9M |
|
85
Insulet
PODD
$9.79B
| $403M | 0.27% |
1,468,080
-47,800
| -3% | -$13M |
|
86
TransDigm Group
TDG
$67.7B
| $396M | 0.27% |
611,194
-2,400
| -0.4% | -$1.51M |
|
87
Carnival Corporation Ltd
CCL
$39.7B
| $385M | 0.26% |
14,588,627
-191,800
| -1% | -$5.37M |
|
88
CVS Health
CVS
$122B
| $366M | 0.25% |
4,382,935
-124,270
| -3% | -$10.2M |
|
89
Citigroup
C
$226B
| $343M | 0.23% |
4,845,046
-85,300
| -2% | -$6.31M |
|
90
LivaNova
LIVN
$4.2B
| $338M | 0.23% |
4,023,725
+1,040
| +0% | +$85.6K |
|
91
Illumina
ILMN
$28.4B
| $337M | 0.23% |
732,808
-15,045
| -2% | -$6.06M |
|
|
KYNB
92
Kyntra Bio
KYNB
$29.4M
| $334M | 0.22% |
501,742
+30,872
| +7% | +$17.8M |
|
93
Apple
AAPL
$4.57T
| $320M | 0.21% |
2,332,800
-388,500
| -14% | -$50.3M |
|
94
Nektar Therapeutics
NKTR
$2.58B
| $310M | 0.21% |
1,205,451
-5,574
| -0.5% | -$1.54M |
|
95
Alaska Air
ALK
$5.58B
| $306M | 0.21% |
5,067,177
-45,870
| -0.9% | -$3.1M |
|
96
Descartes Systems
DSGX
$6.82B
| $301M | 0.2% |
4,355,165
-274,100
| -6% | -$17.3M |
|
|
NUAN
97
DELISTED
Nuance Communications, Inc.
NUAN
| $296M | 0.2% |
5,435,324
-562,410
| -9% | -$29.6M |
|
|
98
XPeng
XPEV
$11.6B
| $295M | 0.2% |
6,646,677
+2,317,087
| +54% | +$79M |
|
99
Goldman Sachs
GS
$303B
| $288M | 0.19% |
759,550
-14,200
| -2% | -$5.08M |
|
100
US Bancorp
USB
$99.6B
| $279M | 0.19% |
4,889,550
-72,300
| -1% | -$4.24M |
|
Similar funds
VAM
Primecap Management's Q2 2021 Portfolio in Review
As of Q2 2021, Primecap Management held 338 positions worth $149B, up 3.8% from $143B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 4.7%. Primecap Management opened 11 new positions and exited 5, leaving the 338-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q2 2021 buy was Xometry: 300,000 shares worth $26.2M.
- Primecap Management added most to Splunk Inc in Q2 2021, an estimated $151M increase.
- Primecap Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $285M.
- Primecap Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $16.9M.
- Primecap Management's ten largest holdings make up 30% of its $149B portfolio in Q2 2021.
- Primecap Management opened 11 new positions and closed 5 in Q2 2021.
- Primecap Management's portfolio value rose 3.8% quarter-over-quarter to $149B.
Based on Primecap Management's 13F filing for Q2 2021, filed 10 Aug 2021.